KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST).
Posted: Feb 27th, 2015
INVEST Publications 
beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.
Posted: Feb 27th, 2015
Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertension.
Posted: Feb 27th, 2015
Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).
Posted: Feb 27th, 2015
Genetic and pharmacogenetic associations between NOS3 polymorphisms, blood pressure, and cardiovascular events in hypertension.
Posted: Feb 27th, 2015
CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response.
Posted: Feb 27th, 2015
Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease.
Posted: Feb 27th, 2015
Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study.
Posted: Feb 27th, 2015